Last reviewed · How we verify
Nitric oxide by inhalation INOMAX — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Nitric oxide by inhalation INOMAX (Nitric oxide by inhalation INOMAX) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nitric oxide by inhalation INOMAX TARGET | Nitric oxide by inhalation INOMAX | Assistance Publique - Hôpitaux de Paris | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nitric oxide by inhalation INOMAX CI watch — RSS
- Nitric oxide by inhalation INOMAX CI watch — Atom
- Nitric oxide by inhalation INOMAX CI watch — JSON
- Nitric oxide by inhalation INOMAX alone — RSS
Cite this brief
Drug Landscape (2026). Nitric oxide by inhalation INOMAX — Competitive Intelligence Brief. https://druglandscape.com/ci/nitric-oxide-by-inhalation-inomax. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab